News

In Lesotho, pills to prevent infection can lead to stigmatisation. But access to a more discreet alternative is under threat ...
Log-in to bookmark & organize content - it's free! Dr. Tyler Goodspeed testified at a House Oversight and Reform Subcommittee on Economic and Consumer Policy hearing on the role of the American ...
Fresenius Kabi's ustekinumab biosimilar Otulfi ™ is now commercially available for both subcutaneous and intravenous formulations With this launch, Fresenius Kabi Canada's immunology biosimilar ...
TORONTO, May 27, 2025 /CNW/ - Fresenius Kabi Canada announces that its ustekinumab biosimilar, developed by Formycon AG, is now commercially available in Canada. Otulfi ™ is indicated for the ...
The Prices page of Fresenius Kabi Oncology Ltd.. captures the information on Price and Volume for a user defined time interval. It also contains the Live Stock Price and Volume, 52 Week High Low, Bid ...
With this launch, Fresenius Kabi Canada's immunology biosimilar portfolio is further expanding, offering more treatment options for patients with chronic autoimmune conditions Tyenne ® is Fresenius ...
Fresenius Kabi, an operating company of Fresenius, announced today that Epinephrine Injection, USP, is now available in the United States in 30 mg per 30 mL multi-dose vials. Epinephrine Injection ...
School of Chemistry and Chemical Engineering, Queen’s University Belfast, David Keir Building, Stranmillis Road, Belfast BT9 5AG, U.K. School of Chemistry and Chemical Engineering, Queen’s University ...
Epinephrine Injection in a 30 mg per 30 mL Multi-Dose Vial is now available from Fresenius Kabi, expanding the company’s offerings of Epinephrine Injection. In December 2024, Fresenius Kabi ...
LAKE ZURICH, Ill.--(BUSINESS WIRE)--#CommittedToLife--Fresenius Kabi, an operating company of Fresenius, announced today that Epinephrine Injection, USP, is now available in the United States in 30 mg ...
Fresenius Kabi, an operating company of Fresenius, announced today that Epinephrine Injection, USP, is now available in the United States in 30 mg per 30 mL multi-dose vials.